News Alexion's Soliris gets new, and lucrative, rare disease indi... Alexion’s rare disease drug Soliris has a new indication after the FDA approved it for a disease that attacks the optic nerves.
News Alexion to file successor to rare diseases drug Soliris New drug is in patient-friendly subcutaneous form
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
